NCT01219036View on ClinicalTrials.gov

The Use of Fractional Exhaled Nitric Oxide in the Identification of Non-adherence in Difficult Asthma

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

October 31, 2008

Primary Completion Date

July 31, 2011

Study Completion Date

July 31, 2011

Conditions
Asthma
Interventions
DRUG

Budesonide (directly observed)

Budesonide 1600 micrograms daily directly observed for 7 days

Trial Locations (1)

BT9 7AB

Regional Respiratory Centre, Belfast City Hospital, Belfast

Sponsors

Collaborators (1)

Asthma UK
All Listed Sponsors
collaborator

Queen's University, Belfast

OTHER

collaborator

Asthma UK

OTHER

collaborator

Northern Ireland Chest Heart and Stroke

OTHER

lead

Liam Heaney

OTHER

NCT01219036 - The Use of Fractional Exhaled Nitric Oxide in the Identification of Non-adherence in Difficult Asthma | Biotech Hunter | Biotech Hunter